Literature DB >> 11156647

Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

M Anti1, A Armuzzi, S Morini, E Iascone, G Pignataro, C Coco, R Lorenzetti, M Paolucci, M Covino, A Gasbarrini, F Vecchio, G Gasbarrini.   

Abstract

BACKGROUND: Alterations in epithelial proliferation and apoptosis in colonic mucosa are associated with an increased risk of colon cancer. It is unclear if these alterations represent a generalised "field defect". AIMS: To analyse segmental patterns of cell proliferation and apoptosis in the colon of subjects with a high and no apparent risk of colon cancer.
METHODS: Pancolonoscopy was performed in 15 patients with resected adenomas (> or =1.5 cm) and in nine subjects without an apparent risk of colorectal cancer. Mucosal biopsies were taken from the right colon, left colon, and sigmoid rectum. Crypt cell proliferation and apoptosis were evaluated, respectively, with bromodeoxyuridine immunohistochemistry and terminal deoxyuridine nucleotidyl nick end labelling of DNA strand breaks. Results are expressed as total labelling index (TLI) and labelling index (LI) for each of the five compartments in which colonic crypts were divided (fourth and fifth compartments were evaluated together) for cell proliferation and as apoptotic index (AI) for apoptosis assessment.
RESULTS: No significant segmental variations in proliferation were found in either group. Compared with controls, adenoma patients had higher TLIs for the right (p>0.05), left (p<0.005), and sigmoid rectum (p<0.05) segments, and higher left colon LIs for crypt compartments (compartment 1, p<0.01; compartment 2, p<0.005; compartment 3, p<0.001; compartments 4-5, p<0.01). Control AIs were similar in all segments but in the adenoma patients left colon and sigmoid rectum AIs were lower than their right colon indexes (p<0.05, p<0.05) and corresponding values for controls (p<0.01, p<0.05).
CONCLUSIONS: The colonic mucosa of patients with past adenomas presents diffuse hyperproliferation and, distally, abnormally distributed proliferating cells and markedly reduced apoptosis. These changes represent a significant risk for malignancies and could account for the high prevalence of left colon tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156647      PMCID: PMC1728212          DOI: 10.1136/gut.48.2.238

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  67 in total

1.  Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice.

Authors:  E M Schmelz; M C Sullards; D L Dillehay; A H Merrill
Journal:  J Nutr       Date:  2000-03       Impact factor: 4.798

Review 2.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

3.  Inhibition of dimethylhydrazine-induced aberrant crypt foci and induction of apoptosis in rat colon following oral administration of the glucosinolate sinigrin.

Authors:  T K Smith; E K Lund; I T Johnson
Journal:  Carcinogenesis       Date:  1998-02       Impact factor: 4.944

Review 4.  The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer.

Authors:  R P Bird; C K Good
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

5.  Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.

Authors:  B Shpitz; Y Bomstein; Y Mekori; R Cohen; Z Kaufman; M Grankin; J Bernheim
Journal:  Am J Surg       Date:  1997-10       Impact factor: 2.565

6.  What is an apoptotic index measuring? A commentary.

Authors:  C S Potten
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 7.  Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist.

Authors:  F G Que; G J Gores
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

8.  Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.

Authors:  C De Filippo; G Caderni; M Bazzicalupo; C Briani; A Giannini; M Fazi; P Dolara
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Aberrant crypt foci in patients with colorectal cancer.

Authors:  L Roncucci; S Modica; M Pedroni; M G Tamassia; M Ghidoni; L Losi; R Fante; C Di Gregorio; A Manenti; L Gafa; M Ponz de Leon
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  23 in total

1.  Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy.

Authors:  Vaibhav Wadhwa; Yash Jobanputra; Haider Al Taii; Prashanthi N Thota; Rocio Lopez; Suryakanth R Gurudu; Madhusudhan R Sanaka
Journal:  Surg Endosc       Date:  2019-03-29       Impact factor: 4.584

Review 2.  Field cancerisation in colorectal cancer: a new frontier or pastures past?

Authors:  Abhilasha Patel; Gyanendra Tripathi; Kishore Gopalakrishnan; Nigel Williams; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 3.  Surveillance of colonic polyps: Are we getting it right?

Authors:  Stewart N Bonnington; Matthew D Rutter
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.

Authors:  Rajendra Karki; R K Subbarao Malireddi; Qifan Zhu; Thirumala-Devi Kanneganti
Journal:  Cell Cycle       Date:  2017-06-09       Impact factor: 4.534

5.  Modeling of stem cell dynamics in human colonic crypts in silico.

Authors:  Yuki Kagawa; Noriko Horita; Hideki Taniguchi; Satoshi Tsuneda
Journal:  J Gastroenterol       Date:  2014-02       Impact factor: 7.527

Review 6.  Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.

Authors:  Sung Whan An; Nam Kyu Kim; Hyun Cheol Chung
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

7.  Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats.

Authors:  Antonella Vetuschi; Giovanni Latella; Roberta Sferra; Renzo Caprilli; Eugenio Gaudio
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 8.  Field defects in progression to gastrointestinal tract cancers.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Katerina Dvorak; Harinder Garewal
Journal:  Cancer Lett       Date:  2007-12-31       Impact factor: 8.679

9.  Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.

Authors:  Pedro Figueiredo; Maria Donato; Marta Urbano; Helena Goulão; Hermano Gouveia; Carlos Sofia; Maximino Leitão; Diniz Freitas
Journal:  Int J Colorectal Dis       Date:  2008-09-04       Impact factor: 2.571

10.  Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite.

Authors:  Tahereh Moradi; Gloria Gridley; Jan Björk; Mustafa Dosemeci; Bu-Tian Ji; Hans J Berkel; Stanley Lemeshow
Journal:  Eur J Cancer Prev       Date:  2008-06       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.